The standard of care for resectable gastric cancers (GCs) includes perioperative chemotherapy (CT) or postoperative chemo/chemoradiotherapy (CRT) strategies. Poor treatment compliance postsurgery suggests that intensified surgical adjuvant treatment is more likely deliverable preceding surgery and, therefore, the safety and efficacy of perioperative cisplatin-capecitabine (CX) with preoperative chemoradiation (preopCRT) were ascertained.

中文翻译：

---

可切除胃癌围手术期顺铂-卡培他滨化疗联合术前放化疗的初步研究。

可切除胃癌（GC）的护理标准包括围手术期化疗（CT）或术后化疗/放化疗（CRT）策略。术后治疗依从性差表明，强化手术辅助治疗更有可能在手术前进行，因此，围手术期顺铂-卡培他滨 (CX) 联合术前放化疗 (preopCRT) 的安全性和有效性得到了确定。